興和集團以興和株式會社(Kowa?Company,Ltd.)為核心，自1894年創業以來，有超過100年的歷史并不斷發展至今。
????興和株式會社醫藥事業部是日本最大的OTC藥品和保健品生產企業之一，研發及生產超過100多種藥物。集團下屬醫藥事業部擁有3個生產工廠和2個研究所，業務范圍涵蓋處方藥、非處方藥、醫療器械、以及保健品的研發、生產和銷售。市場涉及全球。
????興和（上海）醫藥咨詢有限公司作為日本興和株式會社全資附屬的子公司于2007年在上海正式成立，涉及處方藥和OTC藥品/保健品等。
????興和制藥（中國）有限公司于2013年7月9日正式注冊成立，注冊資本3000萬美金，投資總額9000萬美金，興和制藥（中國）肩負研發和生產，業務涉及處方藥、OTC產品以及日用百貨等。興和制藥（中國）的成立為中國業務的發展和成長提供了更多機遇，成為每個興和員工施展才華的廣闊平臺。我們秉承充分整合、利用市場的優良資源，加強管理，全力呵護和改善服務品質；努力發揮聰明才智，同心同德，不辱使命，共同創造和分享美好明天！
????
????Kowa?Group?is?a?complex?corporate?entity?that?consists?of?many?associated?companies?centered?on?Kowa?Company.,?Ltd.?In?our?history?of?over?100?years?since?founded?in?1894,?we?have?continually?made?progress.
????Kowa?(Shanghai)?Pharma?Consulting?Co.,?Ltd.?is?established?in?Dec.2007,?100%?wholly?owned?subsidiary?of?Kowa?Company?Ltd.?In?the?charge?of?the?marketing,?advertising,?marketing?research,?clinical?development?of?drugs,?health?products,?cosmetics,?medical?equipments?that?are?agreed?to?authorize?by?Kowa?Company?in?China.?
????Kowa?Pharmaceuticals?(China)?Co.?Ltd?was?formally?registered?on?July?9,?2013,?registered?capital?of?USD$30?million,?total?investment?up?to?USD$90?million,?aiming?at?research?and?development?and?production,?business?involves?RX,?OTC?products?and?general?merchandise,?etc.
????The?establishment?of?KPC?provides?more?opportunities?for?the?development?and?growth?of?business?in?China,?also?build?a?broader?platform?for?every?employee?to?display?their?talent.Integrating?and?utilizating?of?good?resources,?reinforcing?of?the?management?and?improving?the?quality?of?the?service?are?the?philosophy?of?KPC.?Let?us?work?together?to?create?a?better?tomorrow!
